Skip to content
About
Pipeline
MB-105
News & Publications
Menu
About
Pipeline
MB-105
News & Publications
Contact
Contact
About
Pipeline
MB-105
News & Publications
Menu
About
Pipeline
MB-105
News & Publications
About Us
We have assembled a team of leading cell therapy scientists and drug developers.
Team Members
Sarah Hein, PhD
CEO, Co-Founder
Linkedin-in
Max Mamonkin, PhD
CSO, Co-Founder
Linkedin-in
Malcolm Brenner, MD, Phd
Co-founder and Chair Scientific Advisory Board
Link
Alice Bexon, MD
Acting Chief Medical Officer
Linkedin-in
Victoria Lake, RAC
Head of Regulatory
Linkedin-in
Doris Sanchez
Head of Clinical Development and Product StRategy
Linkedin-in
Bambi Grilley, RAC
Regulatory Strategy and Translation
Linkedin-in
Federica Giordano, PhD
Associate Director of Operations
Linkedin-in
Aaron Vernon, MS
Strategic Advisor Technical Operations
Linkedin-in
Board Members
Sarah Hein, PhD
CEO, Co-Founder
Linkedin-in
Max Mamonkin, PhD
CSO, Co-Founder
Linkedin-in
Thomas Luby, PhD
TMC Ventures
Linkedin-in
Joseph Petrosino, PhD
Baylor College of Medicine
Linkedin-in
Peter Olagunju, MBA
Independent Director
Linkedin-in
Steven Lehmann, MBA
Portal Innovations
(observer)
Linkedin-in
Omar Haneef, MBA
Small Ventures
(observer)
Linkedin-in
Advisory Members
Malcolm Brenner, MD, Phd
Co-founder and Chair Scientific Advisory Board
Helen Heslop, MD
Director Cell and Gene Therapy Center, Baylor College of Medicine
LaQuisa Hill, MD
Assistant Professor Hematology, Baylor College of Medicine
Steve Horwitz, MD
Oncologist, T-cell Lymphoma, Memorial Sloan Kettering Cancer Center
Swaminathan P. Iyer, MD
Professor Department of Lymphoma / Myeloma, MD Anderson Cancer Center
Investors & Partners
Investors & Partners
Scroll Up